Luis Lopez-Cortes
Overview
Explore the profile of Luis Lopez-Cortes including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
180
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sequera-Arquelladas S, Hidalgo-Tenorio C, Lopez-Cortes L, Gutierrez A, Santos J, Tellez F, et al.
Viruses
. 2024 Feb;
16(2).
PMID: 38400035
The continuous pharmacological advances in antiretroviral treatment (ART) and the increasing understanding of HIV drug resistance has led to a change in the paradigm of ART optimization in the setting...
2.
Tarancon-Diez L, Carrasco I, Jimenez de Ory S, Berzosa Sanchez A, Hernanz-Lobo A, Montero-Alonso M, et al.
Biomed Pharmacother
. 2023 Apr;
162:114587.
PMID: 37003032
This study aimed to analyse the long-term effect of direct-acting antivirals (DAAs) in vertically acquired HIV/HCV-coinfected youths. We performed a multicentre, longitudinal and observational study within the Spanish Cohort of...
3.
Dominguez-Dominguez L, Rava M, Bisbal O, Lopez-Cortes L, Portilla J, Podzamczer D, et al.
BMC Infect Dis
. 2022 Apr;
22(1):379.
PMID: 35428209
Background: To study whether the association between the CD4/CD8 ratio variation over time and the development of clinical outcomes vary in late presenters (CD4 count < 350/µL or AIDS event...
4.
Vitalle J, Tarancon-Diez L, Jimenez-Leon M, Terren I, Orrantia A, Roca-Oporto C, et al.
AIDS
. 2020 Apr;
34(8):1249-1252.
PMID: 32287074
: Human CD300a is known to promote the infection by dengue and other enveloped viruses and is overexpressed on CD4 T cells from HIV-1-infected patients. We found that infected CD4+RA-...
5.
Molina J, Ward D, Brar I, Mills A, Stellbrink H, Lopez-Cortes L, et al.
Lancet HIV
. 2018 Jun;
5(7):e357-e365.
PMID: 29925489
Background: Bictegravir, co-formulated with emtricitabine and tenofovir alafenamide, has shown good efficacy and tolerability, and similar bone, renal, and lipid profiles to dolutegravir, abacavir, and lamivudine, in treatment-naive adults with...
6.
Tarancon-Diez L, Dominguez-Molina B, Viciana P, Lopez-Cortes L, Ruiz-Mateos E
EBioMedicine
. 2018 Jan;
28:15-16.
PMID: 29361500
No abstract available.
7.
Falcon-Neyra L, Benmarzouk-Hidalgo O, Madrid L, Noguera-Julian A, Fortuny C, Neth O, et al.
Medicine (Baltimore)
. 2015 Mar;
94(11):e521.
PMID: 25789946
This is a cross-sectional study of 15 aviremic chronic HIV-infected children revealing no differences in immune activation (IA; HLA-DRCD38 CD4 and CD8 T cells, and sCD14) and microbial translocation (MT;...
8.
Pasquau J, Lopez-Cortes L, Mayorga M, Viciana P, Del Mar Arenas M, Rios M, et al.
J Int AIDS Soc
. 2014 Nov;
17(4 Suppl 3):19813.
PMID: 25397557
Introduction: Monotherapy against HIV has undoubted theoretical advantages and has good scientific fundaments. However, it is still controversial and here we will analyze the efficacy and safety of MT with...
9.
Madrid L, Noguera-Julian A, Falcon-Neyra L, Fortuny C, De Felipe B, Torrebadell M, et al.
AIDS
. 2014 Sep;
28(13):1989-92.
PMID: 25259707
A cross-sectional study of 77 chronic HIV-infected children revealed higher levels of biomarkers of inflammation (ultrasensitive C-reactive protein, D-dimer and β-2-microglobulin), immune activation (HLA-DR+ CD38+ CD4+ and CD8+ T cells)...
10.
Vergara S, Macias J, Rivero A, Gutierrez-Valencia A, Gonzalez-Serrano M, Merino D, et al.
Clin Infect Dis
. 2007 Sep;
45(8):969-74.
PMID: 17879910
Background: Transient elastometry (TE) is accurate for detecting significant liver fibrosis and cirrhosis in hepatitis C virus (HCV)-monoinfected patients. However, this procedure has been insufficiently validated in patients with human...